FDA Delays Decision on Sanofi-Aventis (France)'s Pentacel to November 2

PARIS, June 11 (Reuters) - The U.S. Food and Drug Administration has delayed giving a marketing decision on Sanofi-Pasteur's vaccine Pentacel until Nov. 2 from June 8, the French vaccine maker said on Monday, citing technical reasons.